Mr. Dean Sullivan:

I will tell Deputy Chambers what the reference was. In April 2018, Mr. John Pollock from the development board advised that approval of GMP by the end of June was at risk. That was not in respect of the quantum at the time but in regard to the complications of closing the process out. He also stated at that meeting, in response to the then chair of the steering group, that it was too early to estimate the scale of the financial risk.